Status:
COMPLETED
Respiratory Infection Monitoring
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Department of Health and Human Services
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
18+ years
Brief Summary
This study will monitor physical bio-markers such as heart rate, respiratory rate, and temperature to detect potential respiratory infections.
Detailed Description
The advanced, bio-integrated wireless sensor (ADAM) that provides a comprehensive assessment of cardiopulmonary health. The technology employs advanced low-power operation, in-sensor analytics, and cl...
Eligibility Criteria
Inclusion
- ≥18 years old
- Outpatient at start of the study
- Established clinical history of COPD
- Previous hospital or ICU admission for pneumonia or COPD
- Active corticosteroid prescription
- Willingness to participate in the study (long term continuous wear of the device)
- Ability to apply and remove devices and use a mobile application
Exclusion
- Mental or neurodegenerative disease
- Including a current diagnosis of asthma, respiratory disorders (e.g. active tuberculosis, lung cancer, sarcoidosis, lung fibrosis, pulmonary hypertension, interstitial lung diseases); pneumonia or other RTIs not resolved ≤14 days or ≤7 days, respectively, prior to screening
- Skin condition or wound on suprasternal notch.
Key Trial Info
Start Date :
April 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 6 2022
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04362631
Start Date
April 24 2020
End Date
September 6 2022
Last Update
February 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611